Plasma Beta-Amyloid and Metabolic Biomarkers: Age- and Sex-Stratified Analyses Suggest Limited Population-Level Associations
Open Access
Abstract
Background and Objectives: This study examined the relationships between plasma beta-amyloid levels and systemic inflammatory, thyroid, and lipid biomarkers using complementary analytical approaches in a cross-sectional cohort undergoing plasma OAβ and laboratory testing. Materials and Methods: Plasma beta-amyloid, high-sensitivity C-reactive protein (hsCRP), thyroid hormones (TSH and FT4), and lipid profiles (HDL, LDL, and TG) were analyzed. Pearson correlation analyses assessed continuous associations, and one-way analysis of variance (ANOVA) compared biomarker distributions across plasma beta-amyloid categories (low, boundary, high), with additional stratification by age and sex. Multivariable linear regression models adjusted for age and sex evaluated the independence of observed associations. Results: Overall, plasma beta-amyloid showed limited associations with metabolic biomarkers at the population level. A weak inverse correlation with hsCRP was observed in unadjusted analyses in the low group and in males, whereas other biomarkers showed no consistent associations. Additional correlations emerged in selected subgroups but were heterogeneous, based on small samples, and interpreted as exploratory. ANOVA-based comparisons showed no significant differences across plasma beta-amyloid categories in the overall cohort or major strata. Although HDL showed subgroup-specific variation, these associations were not retained after adjustment. Conclusions: Assay-based plasma beta-amyloid categorization was not associated with uniform systemic metabolic alterations. Common inflammatory, thyroid, and lipid biomarkers were not robust population-level correlates and, when present in subgroups, likely reflected context-dependent rather than stable associations.Keywords
This publication has 63 references indexed in Scilit:
- Inflammatory Markers and their Relationship with Cognitive Function in Alzheimer’s Disease and Mild Cognitive Impairment. Systematic Review and Meta-AnalysisNeuroMolecular Medicine, 2025
- Confounding in observational studies evaluating the association between Alzheimer's disease and periodontal disease: A systematic reviewHeliyon, 2023
- Serum lipid traits and the risk of dementia: A cohort study of 254,575 women and 214,891 men in the UK BiobankeClinicalMedicine, 2022
- Plasma Amyloid as Prescreener for the Earliest Alzheimer Pathological ChangesAnnals of Neurology, 2018
- Does transcranial direct current stimulation enhance cognitive and motor functions in the ageing brain? A systematic review and meta- analysisAgeing Research Reviews, 2016
- Insulin resistance predicts brain amyloid deposition in late middle‐aged adultsAlzheimer's & Dementia, 2014
- Associations Between Serum Cholesterol Levels and Cerebral AmyloidosisJAMA Neurology, 2014
- Insulin resistance and amyloidogenesis as common molecular foundation for type 2 diabetes and Alzheimer's diseaseBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2009
- Plasma Amyloid β-Protein and C-reactive Protein in Relation to the Rate of Progression of Alzheimer DiseaseArchives of Neurology, 2008
- Elevated C-Reactive Protein Levels in Overweight and Obese AdultsJAMA, 1999